Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00347867Phase 4Unknown
Phase 4, open-label, single-arm trial of sildenafil in intrauterine growth restriction (IUGR) and preeclampsia, sponsored by Rambam Health Care Campus. Primary endpoints: Uteroplacental perfusion measured by ultrasound Doppler velocimetry at 48 hours, Fetal growth and 1 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00347867.